| Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges T Roberts, J Cohn, K Bonner, S Hargreaves Clinical Infectious Diseases 62 (8), 1043-1048, 2016 | 216 | 2016 |
| Viral load monitoring as a tool to reinforce adherence: a systematic review K Bonner, A Mezochow, T Roberts, N Ford, J Cohn JAIDS Journal of Acquired Immune Deficiency Syndromes 64 (1), 74-78, 2013 | 190 | 2013 |
| Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis JM Freiman, TM Tran, SG Schumacher, LF White, S Ongarello, J Cohn, ... Annals of internal medicine 165 (5), 345-355, 2016 | 179 | 2016 |
| International cooperation to improve access to and sustain effectiveness of antimicrobials C Årdal, K Outterson, SJ Hoffman, A Ghafur, M Sharland, N Ranganathan, ... The Lancet 387 (10015), 296-307, 2016 | 172 | 2016 |
| Sustainable HIV treatment in Africa through viral-load-informed differentiated care A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ... Nature 528 (7580), S68-S76, 2015 | 164 | 2015 |
| Impact of sexual abuse on the HIV-risk-related behavior of adolescents in intensive psychiatric treatment LK Brown, KJ Lourie, C Zlotnick, J Cohn American Journal of Psychiatry 157 (9), 1413-1415, 2000 | 155 | 2000 |
| Disparity in market prices for hepatitis C virus direct-acting drugs I Andrieux-Meyer, J Cohn, ESA de Araújo, SS Hamid The Lancet Global Health 3 (11), e676-e677, 2015 | 112 | 2015 |
| Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study AN Phillips, F Venter, D Havlir, A Pozniak, D Kuritzkes, A Wensing, ... The lancet HIV 6 (2), e116-e127, 2019 | 104 | 2019 |
| Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta‐analysis J Riou, M Aït Ahmed, A Blake, S Vozlinsky, S Brichler, S Eholié, PY Boëlle, ... Journal of viral hepatitis 23 (4), 244-255, 2016 | 104 | 2016 |
| Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses B Lange, J Cohn, T Roberts, J Camp, J Chauffour, N Gummadi, A Ishizaki, ... BMC infectious diseases 17 (1), 87-106, 2017 | 95 | 2017 |
| Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples–a systematic review and meta-analysis B Lange, T Roberts, J Cohn, J Greenman, J Camp, A Ishizaki, L Messac, ... BMC infectious diseases 17, 71-85, 2017 | 94 | 2017 |
| Bartonella Infection in Immunocompromised Hosts: Immunology of Vascular Infection and Vasoproliferation M Mosepele, D Mazo, J Cohn Journal of Immunology Research 2012, 2012 | 80 | 2012 |
| Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review J Greenman, T Roberts, J Cohn, L Messac Journal of viral hepatitis 22 (4), 353-361, 2015 | 79 | 2015 |
| Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries F Bianchi, J Cohn, E Sacks, R Bailey, JF Lemaire, R Machekano, ... The lancet HIV 6 (6), e373-e381, 2019 | 75 | 2019 |
| Translational research for tuberculosis elimination: priorities, challenges, and actions C Lienhardt, K Lönnroth, D Menzies, M Balasegaram, J Chakaya, ... PLoS medicine 13 (3), e1001965, 2016 | 74 | 2016 |
| Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries A Loyse, J Burry, J Cohn, N Ford, T Chiller, I Ribeiro, S Koulla-Shiro, ... The Lancet infectious diseases 19 (4), e143-e147, 2019 | 64 | 2019 |
| Paediatric HIV testing beyond the context of prevention of mother-to-child transmission: a systematic review and meta-analysis J Cohn, K Whitehouse, J Tuttle, K Lueck, T Tran The Lancet HIV 3 (10), e473-e481, 2016 | 58 | 2016 |
| Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act MI Andersson, R Rajbhandari, MC Kew, S Vento, W Preiser, ... The Lancet Global Health 3 (7), e358-e359, 2015 | 57 | 2015 |
| Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines AN Phillips, L Bansi-Matharu, F Venter, D Havlir, A Pozniak, DR Kuritzkes, ... The Lancet HIV 7 (3), e193-e200, 2020 | 45 | 2020 |
| Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study SC Frank, J Cohn, L Dunning, E Sacks, RP Walensky, S Mukherjee, ... The lancet HIV 6 (3), e182-e190, 2019 | 40 | 2019 |
